Press Releases from Stem Cell Innovations, Inc. (UK) (3 total)
direct/ Stem Cell Innovations, Inc. (UK) - Stem Cell Innovations officially open …
Leiden, The Netherlands - June 1, 2006 - Stem Cell Innovations, Inc. (SCLL.OB) announced yesterday that the Company has opened a new R&D facility to commercialise their proprietary platform of human pluripotent stem cells (PCs(TM)) in Europe. The facility is based in Leiden, the Netherlands and encompasses 1,000 m2 of state-of-the-art research laboratories.
"Establishing a site in Europe is part of SCI´s strategy to become a global leading player in…
direct/ Stem Cell Innovations, Inc. (UK) - Stem Cell Innovations, Inc. files pat …
CELLS MAY BE USEFUL IN THERAPIES FOR ALS, PARKINSON´S, MULTIPLE SCLEROSIS AND OTHER NEURODEGENERATIVE DISEASES.
SCOTCH PLAINS, NJ - April 27, 2006 - Stem Cell Innovations, Inc. (OTCBB: SCLL) has filed a patent application protecting the differentiation of its proprietary human pluripotent stem cells (PCs) into neural progenitor cells and purified populations of motor neurons. These cells will initially be used in the Company´s core drug discovery and toxicology platform.…
direct/ Stem Cell Innovations, Inc. (UK) - STEM CELL INNOVATIONS MAKES THEIR HUM …
At Bio2006 Stem Cell Innovations, Inc. (SCLL.OB) announced today that the Company will commercialize their proprietary platform of human pluripotent stem cells in Europe through their newly established European R & D facility in Leiden, the Netherlands.
CEO Dr. James Kelly recently disclosed that SCI has produced multiple lines of human pluripotent stem cells. These cell lines are able to maintain their undifferentiated state and normal chromosome complement. The cells…
